Cargando…

HIV Antiretroviral Medication Neuropenetrance and Neurocognitive Outcomes in HIV+ Adults: A Review of the Literature Examining the Central Nervous System Penetration Effectiveness Score

This literature review summarizes the existing research examining the CNS penetration effectiveness (CPE) score and neurocognitive outcomes (i.e., neuropsychological assessment and neurocognitive screening) in HIV+ individuals. Despite the effectiveness of Combined Antiretroviral Therapy (CART) in r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arentoft, Alyssa, Troxell, Katie, Alvarez, Karen, Aghvinian, Maral, Rivera Mindt, Monica, Cherner, Mariana, Van Dyk, Kathleen, Razani, Jill, Roxas, Michaela, Gavilanes, Melissa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227894/ https://www.ncbi.nlm.nih.gov/pubmed/35746623 http://dx.doi.org/10.3390/v14061151

Ejemplares similares

Japanese encephalitis virus neuropenetrance is driven by mast cell chymase
por: Hsieh, Justin T., et al.
Publicado: (2019)

Social functioning impairments in schizotypy when social cognition and neurocognition are not impaired
por: Aghvinian, Maral, et al.
Publicado: (2018)

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review
por: Aung, Htein Linn, et al.
Publicado: (2020)

Central nervous system penetration-effectiveness rank does not reliably predict neurocognitive impairment in HIV-infected individuals
por: Libertone, Raffaella, et al.
Publicado: (2014)

Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy
por: Winston, Alan, et al.
Publicado: (2013)

The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
por: Rogers, Jeffrey M., et al.
Publicado: (2023)

Metabolic Syndrome and Neurocognitive Function among older Hispanics/Latinos with HIV
por: Marquine, Maria, et al.
Publicado: (2021)

Characterization of HIV-Associated Neurocognitive Impairment in Middle-Aged and Older Persons With HIV in Lima, Peru
por: Diaz, Monica M., et al.
Publicado: (2021)

Neuropsychological Test Norms for the Assessment of HIV-Associated Neurocognitive Impairment Among South African Adults
por: Deist, Melanie, et al.
Publicado: (2023)

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
por: Heaton, Robert K., et al.
Publicado: (2010)

Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis
por: Gao, Chang, et al.
Publicado: (2020)

Neurocognitive performance and quality of life of older adults with HIV on antiretroviral treatment in Northern Thailand
por: Aurpibul, Linda, et al.
Publicado: (2022)

HIV and Neurocognitive Dysfunction
por: Spudich, Serena
Publicado: (2013)

Aberrant Autophagy in Macrophages and Astrocytes after HIV Nef or Antiretroviral Treatment: Contribution to the Pathogenesis of HIV-associated Neurocognitive Disorders
por: Cheney, Laura, et al.
Publicado: (2017)

The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV
por: Sundermann, Erin E., et al.
Publicado: (2022)

The Paradox of HIV Blood–Brain Barrier Penetrance and Antiretroviral Drug Delivery Deficiencies
por: Osborne, Olivia, et al.
Publicado: (2020)

Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder
por: Saloner, Rowan, et al.
Publicado: (2022)

How much do antiretroviral drugs penetrate into the central nervous system?
por: Ene, L, et al.
Publicado: (2011)

Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy
por: Bangirana, Paul, et al.
Publicado: (2017)

Prevalence and Correlates of Neurocognitive Disorders among HIV Patients on Antiretroviral Therapy at a Kenyan Hospital
por: Mugendi, A. G., et al.
Publicado: (2019)

Screening for HIV-Associated Neurocognitive Impairment: Relevance of Psychological Factors and Era of Commencement of Antiretroviral Therapy
por: Herrmann, Susan, et al.
Publicado: (2019)

Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model
por: Saloner, Rowan, et al.
Publicado: (2021)

HIV Nef and Antiretroviral Therapy Have an Inhibitory Effect on Autophagy in Human Astrocytes that May Contribute to HIV-Associated Neurocognitive Disorders
por: Cheney, Laura, et al.
Publicado: (2020)

NEUROCOGNITIVE IMPAIRMENTS IN HIV INFECTION
por: Edwin, Tony, et al.
Publicado: (1999)

HIV Associated Neurocognitive Disorders
por: Zhou, Li, et al.
Publicado: (2013)

HIV-associated neurocognitive disorders
por: Sanmarti, Montserrat, et al.
Publicado: (2014)

Exploring HIV-Associated Neurocognitive Impairment in the Era of Effective Antiretroviral Therapy: A Primary Healthcare Perspective
por: Munsami, Adele, et al.
Publicado: (2022)

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning
por: Bharti, Ajay R, et al.
Publicado: (2016)

Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy
por: Gianella, Sara, et al.
Publicado: (2016)

Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV
por: Nichols, Sharon L., et al.
Publicado: (2015)

Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana
por: Asiedu, Nana, et al.
Publicado: (2020)

Prevalence of Neurocognitive Impairment and Associated Factors Among People Living with HIV on Highly Active Antiretroviral Treatment, Ethiopia
por: Wubetu, Abate Dargie, et al.
Publicado: (2021)

Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV
por: Saloner, Rowan, et al.
Publicado: (2022)

Neuroimaging of HIV-associated neurocognitive disorders
por: Haziot, Michel Elyas Jung, et al.
Publicado: (2015)

Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
por: Rodríguez, Mónica, et al.
Publicado: (2012)

Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders
por: Borjabad, Alejandra, et al.
Publicado: (2011)

Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland
por: Heikinheimo, T, et al.
Publicado: (2015)

Neurocognitive functioning in acute or early HIV infection
por: Moore, David J., et al.
Publicado: (2010)

Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder
por: Davies, Nicholas W.S., et al.
Publicado: (2010)

Cognitive Neuropsychology of HIV-Associated Neurocognitive Disorders
por: Woods, Steven Paul, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_f0e2fk32achkjbolm3flu5c33o